United States Biotechnology & Medical Research

Cognition Therapeutics Inc (CGTX)

Track

The most recent insider trading activity at Cognition Therapeutics Inc. occurred on April 16, 2026. On this date, the Chief Medical Officer, the CEO & President, and the Chief Financial Officer each executed buy transactions for company shares. These represent the latest recorded insider acquisitions for the firm.
Ticker: CGTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cognition Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 16 Apr 2026
Value US$2,226,244.69 | Price 189.36 | Shares 51,256 (+29.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16 B Purchase
Doyle John Brendan

Chief Financial Officer

Officer
51,256 +29.1%
189.36
US$2,226,245 		51,256 +29.1% 189.36 US$2,226,245
2026-04-20 2026-04-16 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
89,466 +30.5%
302.02
US$1,743,704 		89,466 +30.5% 302.02 US$1,743,704
2026-04-20 2026-04-16 B Purchase
Caggiano Anthony

Chief Medical Officer

Officer
92,782 -41.2%
234.54
US$2,186,609 		92,782 -41.2% 234.54 US$2,186,609
2025-02-04 2025-01-31 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
38,851 +inf%
0.77
US$30,001 		38,851 +inf% 0.77 US$30,001
2024-03-14 2024-03-14 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
5,700 +2.0%
1.75
US$9,975 		5,700 +2.0% 1.75 US$9,975
2022-11-29 2022-11-29 B Purchase
1.8
RICHSTONE ELLEN B
Non-Executive Director
10,000 +inf%
2.66
US$26,550 		10,000 +inf% 2.66 US$26,550
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
1,871 +0.6%
2.65
US$4,958 		1,871 +0.6% 2.65 US$4,958
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
12,220 +0.6%
2.65
US$32,379 		12,220 +0.6% 2.65 US$32,379
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
1,973 +0.6%
2.65
US$5,228 		1,973 +0.6% 2.65 US$5,228
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
1,871 +0.6%
2.65
US$4,958 		1,871 +0.6% 2.65 US$4,958
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
12,220 +0.6%
2.65
US$32,379 		12,220 +0.6% 2.65 US$32,379
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
1,973 +0.6%
2.65
US$5,228 		1,973 +0.6% 2.65 US$5,228
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
8,269 +2.8%
1.40
US$11,577 		8,269 +2.8% 1.40 US$11,577
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
54,009 +2.8%
1.40
US$75,613 		54,009 +2.8% 1.40 US$75,613
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
8,722 +2.8%
1.40
US$12,211 		8,722 +2.8% 1.40 US$12,211
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
8,269 +2.8%
1.40
US$11,577 		8,269 +2.8% 1.40 US$11,577
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
54,009 +2.8%
1.40
US$75,613 		54,009 +2.8% 1.40 US$75,613
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
8,722 +2.8%
1.40
US$12,211 		8,722 +2.8% 1.40 US$12,211
2022-11-16 2022-11-15 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
12,000 +96.0%
1.30
US$15,600 		12,000 +96.0% 1.30 US$15,600
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
174,700 +139.9%
1.20
US$209,640 		174,700 +139.9% 1.20 US$209,640
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
1,141,030 +140.1%
1.20
US$1,369,236 		1,141,030 +140.1% 1.20 US$1,369,236
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
184,270 +139.8%
1.20
US$221,124 		184,270 +139.8% 1.20 US$221,124
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
174,700 +139.9%
1.20
US$209,640 		174,700 +139.9% 1.20 US$209,640
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
1,141,030 +140.1%
1.20
US$1,369,236 		1,141,030 +140.1% 1.20 US$1,369,236
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
184,270 +139.8%
1.20
US$221,124 		184,270 +139.8% 1.20 US$221,124
2022-11-16 2022-11-15 B Purchase
2.0
Wallace Peggy
Non-Executive Director
12,500 +49.1%
1.20
US$15,000 		12,500 +49.1% 1.20 US$15,000
2021-10-25 2021-10-13 B Purchase
2.0
Wallace Peggy
Non-Executive Director
3,000 +inf%
12.00
US$36,000 		3,000 +inf% 12.00 US$36,000
2021-10-15 2021-10-13 S Sale
3.1
Ogden CAP Associates, LLC
Large shareholder
74 -0.0%
12.00
US$889 		74 -0.0% 12.00 US$889
2021-10-15 2021-10-13 S Sale
3.1
Golden Seeds Cognition Therapeutics LLC
Large shareholder
33 -0.0%
12.00
US$397 		33 -0.0% 12.00 US$397
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
144,530 +19.1%
12.00
US$1,734,360 		144,530 +19.1% 12.00 US$1,734,360
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
22,129 +33.6%
12.00
US$265,548 		22,129 +33.6% 12.00 US$265,548
2021-10-15 2021-10-13 S Sale
0.9
BIOS Memory SPV I, LP
Large shareholder
90 -0.0%
12.00
US$1,083 		90 -0.0% 12.00 US$1,083
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
23,341 +68.2%
12.00
US$280,092 		23,341 +68.2% 12.00 US$280,092
2021-10-15 2021-10-13 S Sale
3.1
Breedlove Mark H.
Non-Executive Director
12 -0.0%
12.00
US$141 		12 -0.0% 12.00 US$141
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
144,530 +19.1%
12.00
US$1,734,360 		144,530 +19.1% 12.00 US$1,734,360
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
22,129 +33.6%
12.00
US$265,548 		22,129 +33.6% 12.00 US$265,548
2021-10-15 2021-10-13 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director
90 -0.0%
12.00
US$1,083 		90 -0.0% 12.00 US$1,083
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
23,341 +68.2%
12.00
US$280,092 		23,341 +68.2% 12.00 US$280,092
2021-10-14 2021-10-13 B Purchase
0.7
O'Brien James Michael

Chief Financial Officer

Officer
5,000 +inf%
12.00
US$60,000 		5,000 +inf% 12.00 US$60,000
2021-10-14 2021-10-13 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
12,500 +inf%
12.00
US$150,000 		12,500 +inf% 12.00 US$150,000
Explore more

More insider trading research around Cognition Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America